Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …
Confidence has been shaken in Oxford BioMedica following news that its chief executive has stepped down just one month after …
Oxford BioMedica has unanimously rejected two takeover offers from GeneThera, saying the US firm was "not a credible bidder". The …
Aisling Burnand, chief executive of the biotech representative body the BIA welcomed the deal, saying she was pleased the "months …
Lilly is to buy SGX Pharmaceuticals, a biotech company that specialises in cutting-edge technology which helps drug discovery and design. …
The chief executive of an innovative marine biotechnology company has been named Scottish entrepreneur of the year in healthcare. Dr …
Shire is set to acquire German biotech firm Jerini, in a bid to expand its portfolio of treatments for rare …
France has re-branded its leading biotech cluster the ‘Alsace Biovalley’ to help the region compete for investment in Europe and …
A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …
A new comprehensive survey of the world's biotechnology industry shows the sector to be in great health, with indications of …
Eisai is to acquire Morphotek for $325 million, making it the latest pharma company to buy outright a biotech company …
In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …
Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …
At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …
Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …